Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol
; 125(3): 621-4, 2012 Jun.
Article
in En
| MEDLINE
| ID: mdl-22446622
Full text:
1
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Peritoneal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Fallopian Tube Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Gynecol Oncol
Year:
2012
Type:
Article
Affiliation country:
United States